Alessandra Cesano
Chief Medical Officer, Essa Pharma (United States).
Companies
- ZymeworksBoard member Feb 9, 2024 to now1
- Summit TherapeuticsBoard member Nov 17, 2022 to now2
- Puma BiotechnologyBoard member Aug 2, 2022 to now3
- Essa Pharma (United States)Chief Medical Officer Oct 1, 2020 to Mar 28, 20244
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Puma Biotechnology PBYI56,700 shares5$605.6K at $10.68Sep 14, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Sep 14, 2026Sold 62,150 shares at $9.12 of Puma Biotechnology5
- Sep 14, 2026Exercised options 50,000 shares at $2.93 of Puma Biotechnology5
- Jun 11, 2026Granted 27,000 shares of Puma Biotechnology6
- Jul 18, 2025Sold 27,000 shares at $3.37 of Puma Biotechnology7
- Jun 13, 2025Sold 12,150 shares at $3.40 of Puma Biotechnology8
- Jun 11, 2025Granted 27,000 shares of Puma Biotechnology9
- Jun 18, 2024Granted 27,000 shares of Puma Biotechnology10
- Jun 13, 2023Granted 27,000 shares of Puma Biotechnology11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARZymeworks, Board member
- 2SEC EDGARSummit Therapeutics, Board member
- 3SEC EDGARPuma Biotechnology, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 15, 2026
- 7SEC EDGARForm 4 filed Jul 22, 2025
- 8SEC EDGARForm 4 filed Jun 17, 2025
- 9SEC EDGARForm 4 filed Jun 13, 2025
- 10SEC EDGARForm 4 filed Jun 21, 2024
- 11SEC EDGARForm 4 filed Jun 15, 2023